Navigation Links
Inserm announces the recipients of its 2012 prizes

This press release is available in French.

The 2012 Inserm prizes for medical research will be awarded at a ceremony at the Collge de France on Monday 3 December 2012. This year, the grand prize will be awarded to Philippe Sansonetti in the presence of Marisol Touraine, France's Minister of Social Affairs and Health, Genevive Fioraso, France's Minister of Higher Education and Research, and Professor Andr Syrota, Chairman and CEO of Inserm. The grand prize is awarded each year to honour a member of the scientific research community whose work has contributed to advancing knowledge of human physiology, therapeutics and health in general.

Inserm Grand Prize Philippe Sansonetti

The recipient of the 2012 Grand Prize is Professor Philippe Sansonetti, the director of the Microbial Colonisation and Invasion of Mucosa unit (Inserm Unit 786) at the Institut Pasteur in Paris, in recognition of his research on microbial infection.

Prof. Sansonetti was the first to update the genetic bases in bacteria, particularly in Shigella, which causes dysentery, and which he studied the entire sequence of steps that are required for infection.

Prof. Sansonetti coordinates, along with Pascale Cossart, the Integrative Biology of Emerging Infectious Diseases laboratory of excellence.

International Prize Ingrid Grummt

The recipient of Inserm's International Prize is Professor Ingrid Grummt of the German Cancer Research Centre of Heidelberg in recognition of her epigenetics research on the molecular mechanisms that regulate gene expression.

Honour Prize Jean-Paul Soulillou

The recipient of Inserm's Honour Prize is Professor Jean-Paul Soulillou, who heads Inserm's Lymphocyte Regulation and Tolerance team at the Centre for Transplantation and Immunology Research (Inserm Unit 1064) in Nantes, France, in recognition of his work on transplant tolerance.

Prof. Soulillou is notably behind the development of a "smart" antibody that is widely used to prevent transplant rejection and his research interests include the development of highly effective immunosuppressants.

Research Prizes Sophie Ugolini and Jessica Zucman-Rossi

The Research Prizes are awarded to:

- Sophie Ugolini, an Inserm research director at the Marseille-Luminy Immunology Centre, for her work on the function of natural killer cells (NK cells).

- Jessica Zucman-Rossi, director of the Functional Genomics of Solid Tumours unit in Paris (Inserm Unit 674), for her work on the identification and understanding of the role of gene interactions in human tumours, particularly the Ewing family of tumours.

Innovation Prize Alain de Cesare and Marc Lopez

The Innovation Prizes are awarded to two engineers in recognition of their support in guiding research:

- Alain de Cesare, an Inserm research engineer at the Functional Imaging Laboratory (Inserm Unit 678) in Paris and a designer of medical imaging analysis software.

- Marc Lopez, an Inserm research engineer at the Marseille Oncology Research Centre (Inserm Unit 1068) who identified the cellular adhesion molecules known as nectins.

Contact: Inserm press office
INSERM (Institut national de la sant et de la recherche mdicale)

Related medicine news :

1. EPSRC announces new green engineering projects
2. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces Faster Weight Loss than a "No-Diet" Weight Loss Diet
3. Gabrielles Angel Foundation for Cancer Research announces 2 collaborative research grants
4. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
5. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
6. Plastic and Reconstructive Surgery Journal announces global expansion initiatives
7. NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
8. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
9. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
10. CRF announces late breaking trials and first report investigations to be presented at TCT 2012
11. SfN announces winners of brain awareness video contest
Post Your Comments:
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: